StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) :

StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report released on Sunday. The firm issued a sell rating on the stock. OncoCyte Trading Up 0.3 % NASDAQ:OCX opened at $2.94 on Friday. OncoCyte has a one year low of $2.08 and a one year high of $7.20. The company has […]

Related Keywords

United States , , Nasdaq , Cubist Systematic Strategies , Oncocyte Corporation , Raymond James Financial Services Advisors Inc , Vanguard Group Inc , Goldman Sachs Group Inc , Free Report , James Financial Services Advisors , Sachs Group , Get Free Report , Cyte Corporation , Oncocyte Daily , Oncocyte , Nasdaq Ocx , Socx , Medical , Initiated Coverage , Stocknews Com ,